annual net income:
-$463.66M-$135.59M(-41.33%)Summary
- As of today (September 18, 2025), RXRX annual net profit is -$463.66 million, with the most recent change of -$135.59 million (-41.33%) on December 31, 2024.
- During the last 3 years, RXRX annual net income has fallen by -$277.18 million (-148.64%).
- RXRX annual net income is now -649.30% below its all-time high of -$61.88 million, reached on December 31, 2019.
Performance
RXRX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$171.90M+$30.59M(+15.11%)Summary
- As of today (September 18, 2025), RXRX quarterly net profit is -$171.90 million, with the most recent change of +$30.59 million (+15.11%) on June 30, 2025.
- Over the past year, RXRX quarterly net income has dropped by -$74.36 million (-76.23%).
- RXRX quarterly net income is now -833.01% below its all-time high of -$18.42 million, reached on March 31, 2020.
Performance
RXRX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$649.13M-$74.36M(-12.94%)Summary
- As of today (September 18, 2025), RXRX TTM net profit is -$649.13 million, with the most recent change of -$74.36 million (-12.94%) on June 30, 2025.
- Over the past year, RXRX TTM net income has dropped by -$274.21 million (-73.14%).
- RXRX TTM net income is now -3423.30% below its all-time high of -$18.42 million, reached on March 31, 2020.
Performance
RXRX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RXRX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.3% | -76.2% | -73.1% |
| 3 y3 years | -148.6% | -162.2% | -177.5% |
| 5 y5 years | -649.3% | -807.4% | -1637.2% |
RXRX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -148.6% | at low | -199.0% | +15.1% | -177.5% | at low |
| 5 y | 5-year | -649.3% | at low | -807.4% | +15.1% | -1637.2% | at low |
| alltime | all time | -649.3% | at low | -833.0% | +15.1% | -3423.3% | at low |
RXRX Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$171.90M(-15.1%) | -$649.13M(+12.9%) |
| Mar 2025 | - | -$202.49M(+13.2%) | -$574.77M(+24.0%) |
| Dec 2024 | -$463.66M(+41.3%) | -$178.91M(+86.7%) | -$463.66M(+22.7%) |
| Sep 2024 | - | -$95.84M(-1.7%) | -$377.75M(+0.8%) |
| Jun 2024 | - | -$97.54M(+6.7%) | -$374.93M(+5.9%) |
| Mar 2024 | - | -$91.37M(-1.7%) | -$354.11M(+7.9%) |
| Dec 2023 | -$328.07M(+37.0%) | -$93.00M(-0.0%) | -$328.07M(+12.1%) |
| Sep 2023 | - | -$93.02M(+21.2%) | -$292.56M(+12.5%) |
| Jun 2023 | - | -$76.73M(+17.4%) | -$259.99M(+4.5%) |
| Mar 2023 | - | -$65.33M(+13.6%) | -$248.82M(+3.9%) |
| Dec 2022 | -$239.48M | -$57.49M(-4.9%) | -$239.48M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$60.45M(-7.8%) | -$246.92M(+5.6%) |
| Jun 2022 | - | -$65.56M(+17.1%) | -$233.90M(+10.5%) |
| Mar 2022 | - | -$55.98M(-13.8%) | -$211.74M(+13.5%) |
| Dec 2021 | -$186.48M(+114.3%) | -$64.93M(+36.9%) | -$186.48M(+53.4%) |
| Sep 2021 | - | -$47.43M(+9.3%) | -$121.55M(+24.0%) |
| Jun 2021 | - | -$43.40M(+41.3%) | -$97.99M(+33.3%) |
| Mar 2021 | - | -$30.72M(+28.7%) | -$73.53M(+20.1%) |
| Dec 2020 | -$87.01M(+40.6%) | - | - |
| Sep 2020 | - | -$23.87M(+26.0%) | -$61.24M(+63.9%) |
| Jun 2020 | - | -$18.94M(+2.8%) | -$37.37M(+102.8%) |
| Mar 2020 | - | -$18.42M | -$18.42M |
| Dec 2019 | -$61.88M | - | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual net profit?
- What is the all time high annual net income for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual net income year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly net profit?
- What is the all time high quarterly net income for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is Recursion Pharmaceuticals, Inc. TTM net profit?
- What is the all time high TTM net income for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. TTM net income year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual net profit?
The current annual net income of RXRX is -$463.66M
What is the all time high annual net income for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual net profit is -$61.88M
What is Recursion Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, RXRX annual net profit has changed by -$135.59M (-41.33%)
What is Recursion Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of RXRX is -$171.90M
What is the all time high quarterly net income for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly net profit is -$18.42M
What is Recursion Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, RXRX quarterly net profit has changed by -$74.36M (-76.23%)
What is Recursion Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of RXRX is -$649.13M
What is the all time high TTM net income for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high TTM net profit is -$18.42M
What is Recursion Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, RXRX TTM net profit has changed by -$274.21M (-73.14%)